Background: Insulin resistance not only occurs in obesity, but also in lipodystrophy. Although adipose tissue mass affects metabolic fluxes and participates in interorgan crosstalk, the role of energy metabolism within white adipose tissue for insulin resistance is less clear. contributes to the secretion of lipid metabolites and lactate, which are linked to insulin resistance in peripheral tissues. However, the relevance of adipose tissue energy metabolism for the regulation of human insulin sensitivity remains to be further elucidated.
| INTRODUCTION
Interestingly, dysfunctional adipose tissue either due to adipose tissue expansion resulting from chronic overnutrition and inadequate physical activity 1 or due to decreased adipose tissue mass in lipodystrophy associates with marked insulin resistance. 2 Both conditions will lead to impaired lipid storage in adipose tissue, thereby giving rise to excessive systemic availability of lipids, which can cause insulin resistance in distant tissues.
processes, like cell signalling, differentiation and growth. 4 The aim of this review was to summarize studies in humans, cell cultures and mouse models, both in vivo and in vitro, to investigate the role of mitochondrial function in white adipose tissue for systemic insulin sensitivity. Additionally, this review includes studies analysing the relevance of lipogenesis and lipolysis in human adipose tissue for insulin resistance. Furthermore, this review examines the link of adipose tissue mitochondrial function with lipogenesis and lipolysis in insulin-sensitive and insulin-resistant humans.
We performed a PubMed literature search between September 2017 and January 2018 for publications in English language with combination of the terms: "Adipose tissue AND insulin resistance OR type 2 diabetes AND lipogenesis OR lipolysis OR mitochondrial function." We identified 24 original papers on humans, 14 publications in cell cultures, 36 publications on animal models and 16 reviews.
In the absence of prospective or outcome studies in humans, we reviewed only studies with cross-sectional cohort design as well as in vitro studies in cultured adipocytes and transgenic animal models with mechanistic approaches for the better understanding of the results obtained from human studies. We further included only those studies, which reported data on lipogenesis, lipolysis or mitochondrial function in white adipose tissue of insulin-resistant human. We included only studies that assessed insulin sensitivity using gold standard methodology (hyperinsulinemic-euglycemic clamp) or accepted surrogate parameters (homeostasis model assessment or insulin sensitivity index). Finally, a total of 14 original papers on humans, four on cell cultures, 16 on animal models and eight reviews met these criteria. Additionally, we identified publications from the reference lists of the described publications or from the authors' knowledge related to this topic. Of note, we excluded studies focusing on brown adipose tissue (BAT) or analysing possible effects of BAT induction ("browning" or "beiging") in insulin-resistant humans. While experimental BAT induction associates with lower body weight and improved glycemic control, 5 there is currently no evidence for changes in BAT mass and function under common physiological and pathophysiological conditions in humans. In this review, the term "adipose tissue" therefore refers only to any compartments of white adipose tissue.
| INSULIN RESISTANCE AND COMPARTMENTATION OF WHITE ADIPOSE TISSUE

| Assessment of adipose tissue insulin resistance
In vivo, tracer-dilution techniques using stable isotopelabelled glycerol or FA tracers during intravenous insulin infusion represent the current gold standard to quantify insulin sensitivity of human adipose tissue. 6 Employing this method, higher systemic glycerol or free FA appearance reflects impaired insulin-mediated suppression of lipolysis and thereby determines insulin resistance of adipose tissue in vivo. Alternatively, lower reduction of the plasma concentrations of endogenous (unlabelled) free FA during the multistep hyperinsulinemic-euglycemic clamp test also indicates adipose tissue insulin resistance. The multistep euglycemic clamp procedure further allows to assess insulin sensitivity and responsiveness in liver and skeletal muscle. Combined with continuous infusion of a glucose tracer, the clamp yields insulin-stimulated rates of glucose disappearance as a measure of skeletal muscle insulin sensitivity and insulin-mediated suppression of rates of endogenous glucose production as a measure of hepatic insulin sensitivity. 7 Finally, the adipose tissue insulin resistance index (Adipo-IR), calculated from fasting plasma free FA and insulin levels, represents an accepted surrogate parameter for adipose tissue insulin resistance, but does not measure insulin action directly. 8 In vitro, reduced insulin-stimulated uptake of labelled deoxyglucose defines insulin resistance in cultured adipocytes. 9 It has been suggested that adipose tissue insulin resistance may even appear before the onset of whole-body insulin resistance from impairment of intracellular insulin signalling 10 and insulin-stimulated glucose uptake into adipocytes. 11 However, most in vivo and in vitro studies did not completely evaluate the dose-response relationships for insulin action and mechanistic studies comparing insulin sensitivity of adipose tissue vs skeletal muscle and liver or their reciprocal interaction in human are still missing.
| Adipose tissue compartments
Human adipose tissue consists of visceral (VAT) and subcutaneous adipose tissue (SAT), comprising a deep (DSAT) and superficial (SSAT) compartment. Depending on sexspecific differences, VAT accounts for 6%-20%, SAT for 80%-90% of whole-body adipose tissue 12 and DSAT accounts for 51% of SAT in females and for 66% in males. 13 Whole-body and hepatic insulin resistance correlates positively with volume of VAT, 14 but not of SAT.
Compared to women, men have higher VAT, whereas women have increased SAT volume, 15 which is thought to have a protective function on insulin sensitivity. 16 Furthermore, White Americans have higher VAT volume compared to Hispanics and African Americans. In contrast, South Asians have more VAT and a higher risk to develop type 2 diabetes than Caucasians. 17 Finally, abdominal VAT volume increases during ageing independently of sex and body fat mass, which is consistent with the higher risk for type 2 diabetes in the elderly.
Of note, lipolytic activity and insulin sensitivity are different in the different compartments of human adipose tissue. Insulin-resistant obese humans show a greater lipolytic response to catecholamines, but a decreased sensitivity to the antilipolytic effects of insulin in VAT compared to SAT in vivo 18, 19 ( Figure 1 ). Enhanced portal plasma FA delivery to the liver, resulting from higher catecholamine response in VAT, may promote hepatic and whole-body insulin resistance. 20 On the other hand, reduced lipolytic activity and higher insulin sensitivity indicate a greater capacity of SAT to store excess FA in the form of triacylglycerols and protect other tissues from lipotoxic effects. 16 Accordingly, humans with reduced abdominal SAT, but higher VAT volume, exhibit a phenotype similar to that of patients with lipodystrophy, whole-body insulin resistance and fatty liver. 21 Furthermore, abdominal SAT is divided by Scarpa's fascia into two putative metabolically distinct subdepots, referred to as deep (DSAT) and superficial (SSAT) layers 22, 23 (Figure 2 ). Higher SSAT volume associates negatively with glycated haemoglobin A1c and positively with high-density lipoprotein cholesterol in patients with type 2 diabetes. 24 SSAT may therefore have a similar protective function as the metabolically inert femoral fat depot. 25 On the other hand, VAT and DSAT share inflammatory characteristics, which include higher macrophage infiltration compared to SSAT and associate with cardiovascular and liver diseases. 13, 26 DSAT, but not SSAT volume, showed a similar positive association with insulin resistance as reported for VAT volume. 23 In contrast to VAT, DSAT associated with hepatic and whole-body insulin resistance only in males. 27 Furthermore, DSAT volume was suggested to be an even better predictor of fasting insulin levels than VAT volume. 13 Higher lipolysis in DSAT compared to SSAT was suggested to explain the association between DSAT and insulin resistance. 28 Although no functional data and hormone-sensitive lipase (HSL) for breakdown of triacylglycerol (TAG) in diacylglycerols (DAG) and monoacylglycerols (MAG). 88 Activation of the insulin receptor (IR) cascade via insulin receptor substrate (IRS) phosphorylation and subsequent phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB, Akt) activation 89, 90 leads to glucose transporter 4 (GLUT4) translocation into adipocyte membrane and activation of mammalian target of rapamycin (mTORC1). 91, 92 The antilipolytic effect of insulin is mediated via various negative feedback signals resulting from IR activation. Akt activated mTORC1 lowers lipolysis via inhibition of β-adrenoreceptor-induced ATGL transcription, while PKA inhibits mTORC1. 91 Of note, mTORC1 activates sterol regulatory element-binding protein (SREBP1c) for the induction of lipogenic pathways. The insulin signalling cascade inhibits lipolysis through activation of adipose-specific phospholipase A2 (AdPLA2), which inhibits adenylate cyclase. 93, 94 PKA activity is reduced by Akt via decreased cAMP levels resulting from phosphodiesterase activation. 95 Diacylglycerol acyltransferase (DGAT), fatty acids (FA) and monoacylglycerol acyltransferase (MGAT). The boxes next to cell surface receptors indicate the depot, in which the changes are most marked. Unfilled thick arrows indicate the direction of change in insulin-resistant state comparing insulin action between SSAT and DSAT are available, higher GLUT4 protein expression in SSAT may point to increased glucose metabolism in this depot. 29 Of note, it has already been shown that not only GLUT4 translocation, but also GLUT4 protein expression is induced by insulin and leads to higher glucose uptake in adipocytes. 30, 31 However, functional data analysing FA metabolism in these depots to explore the relevance for insulin-resistant human are missing.
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| FATTY ACID TURNOVER OF ADIPOSE TISSUE
| Lipogenesis
Adipose tissue has a major effect on lipid metabolism and also contributes to circulating levels of glucose and FA. Circulating FA is derived from dietary fat intake, but also from endogenous de novo lipogenesis (DNL), regulated mainly by acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS; Figure 3 ). Also dietary intake of carbohydrate rich food leads to activation of FAS in adipose tissue, which facilitates conversion of glucose to FA. 32 Compared to liver, in the postprandial state, adipose tissue DNL is quantitatively lower. When glycogen stores are saturated, additional hepatic glucose uptake leads to DNL, followed by triacylglycerol export to adipose tissue for storage in healthy humans. 33 Interestingly, DNL in adipose tissue and in liver correlate inversely suggesting a reciprocal interaction between both depots. 34 Similarly, adipose tissue DNL is compensatory increased, when hepatic DNL is reduced at least in mice with hepatocyte-specific deficiency of an escort protein transporting sterol regulatory element-binding protein (SREBP), named SREBP cleavage-activating protein (SCAP), to activate DNL. 35 In cultured human adipocytes, insulin increased FAS expression and activity via glucose 6-phosphate and carbohydrate-responsive element-binding protein (ChREBP). [36] [37] [38] [39] ChREBPβ transcription, resulting from GLUT4-mediated increase in intracellular glucose levels and stimulation of the ChREBPα isoform, led to FAS-activated increase of DNL in adipose tissue. 38, 39 ACC seems to be activated independent of insulin by its substrate citrate 40 to initiate DNL. Conversely, fasting with low circulating insulin levels resulted in lower adipose tissue glucose uptake and DNL. 41 Thus, the presence of insulin and intact insulin signalling is crucial for glucose uptake and subsequent adipocyte DNL. Consistent with this, insulin-resistant humans present with lower expression of the lipogenic genes, FAS and ACC 34, 42, 43 (Table 1) . This is associated with reduced insulin-stimulated incorporation of labelled glucose carbon in triacylglycerols in both SAT and VAT. 44 There is increasing evidence from rodent models that impaired adipocyte DNL contributes to the pathogenesis of whole-body insulin resistance. 45 In a murine model, reduction of the FA binding protein adipocyte protein 2 (aP2) resulted in increased DNL in adipose tissue, enhanced insulin signalling in adipocytes and improved whole-body insulin sensitivity. 46 A product of DNL from adipose tissue, palmitoleate, may serve as a systemic signal by stimulating muscle insulin action and suppressing hepatosteatosis. 46 Besides palmitoleate, DNL generates other metabolites such as FA esters of hydroxy FA, which also contribute to interorgan crosstalk between adipose tissue and insulin-sensitive tissues to regulate insulin sensitivity and energy metabolism, as reviewed recently. 47 Previous studies in humans identified positive associations between DNL in VAT as well as SAT and wholebody insulin sensitivity 43, 44, [48] [49] [50] (Table 1) . Insulin-resistant obese humans with elevated fasting glucose and insulin levels present with lower ChREBPβ, FAS and GLUT4 expression in VAT than nonobese humans. 34 In contrast,
ChREBPβ and FAS mRNA levels are increased in the liver of insulin-resistant obese compared to nonobese controls. 34 Of note, one study reported higher adipose tissue FAS gene expression in insulin-resistant compared to insulin-sensitive humans 51 (Table 1) . Nevertheless, these findings are in contrast to several previous reports 34, [42] [43] [44] 48, 52 (Table 1) and may arise from differences in nutritional behaviour 42 or mitochondrial function in adipose tissue. Importantly, 
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| the comparable FAS protein expression between the groups did not support the differences in FAS gene expression, 51 which weakens the relevance of the results of this study.
| Lipolysis
Adipose tissue lipolysis occurs by breakdown of triacylglycerols to diacylglycerols (DAG), monoacylglycerols (MAG), and finally glycerol and FA by the sequential action of adipose triacylglycerol lipase (ATGL), hormonesensitive lipase (HSL) and monoacylglycerol lipase (MGL). The action of insulin promotes inhibition of lipolysis in adipose tissue and reduction of circulating plasma glycerol and FA (Figure 1 ). During fasting, low insulin concentrations as well as activation of the β-adrenoreceptor signalling by catecholamines, which are released by stimulation of the sympathetic nervous system due to low blood glucose levels, favour triacylglycerol breakdown with augmented glycerol and FA release from adipose tissue. Activation of the β-adrenoreceptor signalling cascade leads to induction of adenylate cyclase. Protein kinase A (PKA) is activated by the conversion of ATP to cyclic adenosine monophosphate (cAMP), which is catalyzed by adenylate cyclase. Finally, ATGL and HSL are activated by PKA, leading to breakdown of triacylglycerol in DAG (Figure 1 ). Adipose tissue of obese humans is characterized by low-grade inflammation with progressive immune cell infiltration. Infiltrated immune cells are stimulated by FA to release pro-inflammatory cytokines, such as tumour-necrosis factor α (TNFα) and interleukin-1β (IL-1β), which in turn activate lipolysis in adipocytes. 53 Increased lipolysis in adipose tissue raises the systemic availability of lipids, which cause insulin resistance in distant tissues. 
F I G U R E 4
Systemic consequences of impaired mitochondrial function and insulin resistance in human white adipose tissue. Abnormal mitochondrial function in human white adipose tissue impairs secretion of autocrine, paracrine and endocrine mediators affecting insulin sensitivity in skeletal muscle and liver. Impaired mitochondrial function increases anaerobic energy metabolism in white adipose tissue to compensate for decreased pyruvate turnover in mitochondria. Increased fasting lactate level in plasma may induce hepatic gluconeogenesis and impair glucose uptake in skeletal muscle. Insulin-resistant obese humans show inflammation of white adipose tissue, which further leads to enhanced cytokine release with subsequent increased lipolysis in white adipose tissue. Inflammation and adipocyte hypertrophy can further lead to hypoxia in white adipose tissue, leading to activation of hypoxia-inducible factor 1 α (HIF1α) with subsequent inhibition of sirtuin 2 (SIRT2) followed by diminished deacetylation of peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) leading to impaired mitochondrial function. Abnormal mitochondrial function, decreased lipogenesis and increased lipolysis in white adipose tissue increase the release of lipid metabolites (glycerol and fatty acids) and cytokines (TNFα and IL-1β), which further promotes ectopic lipid accumulation and decrease glucose uptake in liver and skeletal muscle. Fatty acid (FA) and reactive oxygen species (ROS). Dotted arrows indicate suspected effects of depicted substrate. Unfilled thick arrows indicate the direction of change in insulin-resistant state deficiency, 54, 55 both decreasing lipolysis, recent evidence in humans questions the associations between whole-body insulin resistance and increased lipolysis in adipose tissue 44, 56 (Table 1) . Human carriers of HSL gene mutations present with dyslipidaemia, hepatic steatosis, impaired glucose tolerance, partial lipodystrophy and increased risk for the development of type 2 diabetes. 56 Of note, changes in HSL expression will also be present in other tissues, thereby making it difficult to identify the specific role of adipose tissue for the observed results. Basal and isoproterenol-stimulated lipolysis decreased together with insulins' antilipolytic effect in SAT. Insulin receptor and insulin receptor substrate 1 protein expression were lower, while macrophage infiltration was higher in SAT. Additionally, ATGL protein expression and genes involved in DNL and triacylglycerol synthesis were reduced in SAT. Furthermore, all individuals, who were homozygous for the HSL mutation, displayed type 2 diabetes. 56 Interestingly, an 8-week treatment with nicotinic acid to inhibit lipolysis in human adipose tissue resulted in upregulation of lipogenic gene expression in SAT of obese men. 55 The authors conclude that decreased lipolysis in adipocytes reshapes energy fluxes into adipose tissue via induction of DNL, which leads to improved whole-body insulin sensitivity.
Finally, lipolysis-dependent secretion of aP2 from adipocytes activates hepatic glucose production in lean mice and cultured hepatocytes. 57 Inhibition of ATGL and HSL activity could further prevent aP2 secretion from adipocytes. 58 Since neutralization of secreted aP2 prevented from diabetes in obese mice, 57 these findings could explain the link between adipose tissue lipolysis and insulin resistance. Nevertheless, human studies for the effect of ATGL and HSL inhibition on whole-body insulin resistance are still missing.
| MITOCHONDRIAL FUNCTION
OF ADIPOSE TISSUE
| Mitochondrial morphology and density of adipose tissue
The spherical human white adipocyte contains a single lipid droplet, which creates a small surrounding cytosol with few mitochondria. Human VAT features higher mitochondrial density with twice the amount of mitochondria per milligram of tissue than SAT. 59 Of note, possible differences in mitochondrial density between DSAT and SSAT compartments are unknown. In insulin-resistant humans and type 2 diabetes patients, SAT has a lower mitochondrial density. 60, 61 The lower gene expression of PPARγ 1 coactivator α (PGC1α) suggests reduced mitochondrial biogenesis in insulin-resistant patients with type 2 diabetes. 61 Although mitochondrial density in SAT correlates positively with whole-body insulin sensitivity, 60, 62 age and BMI may influence this association. 62 Nevertheless, the latter study also reported a strong correlation between mitochondrial density and ex vivo lipogenesis in adipose tissue.
| Mitochondrial lipid handling
During prolonged fasting, adipose tissue-derived FA serves as substrates for mitochondrial β-oxidation to provide or ATP generation and to maintain whole-body energy homeostasis. 63 In turn, ATP is required for insulin signalling in adipocytes, 64 and thereby for insulin-stimulated antilipolytic effects 60 and lipogenesis. 65 AMP-activated protein kinase (AMPK), activated by the turnover of intracellular ATP to cAMP, increases ATP-producing pathways 66 such as glycolysis, β-oxidation or glucose uptake, to sustain sufficient energy levels in adipose tissue. 67 On the other hand, inhibition of AMPK leads to activation of ATP-dependent pathways like protein, cholesterol, glycogen or FA synthesis. 67 In particular, inactivation of PKA via cAMP induction was shown to increase AMPK activity, which reduced HSL activity in adipocytes. 68 Consistent with these findings, activation of AMPK by adrenoreceptor agonists lowered lipolysis in adipocytes. 69 Interestingly, inhibition or genetic deletion of ATGL, resulting in lower lipolysis, led to reduced catecholamine-induced AMPK activation. 70 These observations suggest that AMPK activation is reciprocally regulated by lipolytic activity and does not decrease lipolysis via downstream signalling from catecholamine-stimulated signalling. Nevertheless, studies elucidating mechanism of AMPK activation during chronic states of increased lipolysis are still missing, and interpretation of these findings for whole-body insulin resistance remains difficult.
| Mitochondrial function in insulin resistance
Mitochondrial respiration expressed per milligram of tissue is higher in human VAT than in SAT. 59 However, because of greater mitochondrial density in VAT, mitochondrial respiration is lower in VAT after normalization for mitochondrial content. 59 Of note, possible differences in mitochondrial function and density between DSAT and SSAT compartments are unknown.
Proteins relevant for mitochondrial function are lower in SAT of insulin-resistant compared to insulin-sensitive human. 71 Accordingly, abnormal mitochondrial function in adipose tissue leads to systemic insulin resistance in mice. 72 Development of insulin resistance was suggested to result from decreased production of energy sources in mitochondria for highly energy-dependent pathways in adipose tissue. 73 Adequate lipogenesis, lipolysis, secretion of adipokines, 74 insulin signalling 75 and glucose uptake 76 revealed to be dependent on sufficient energy sources. Abnormal mitochondrial function in human adipose tissue impairs secretion of autocrine, paracrine and endocrine mediators affecting whole-body insulin sensitivity. 77 Impaired mitochondrial function increases anaerobic energy metabolism in adipose tissue to compensate for decreased pyruvate turnover in mitochondria. Hypertrophic adipocytes, as assessed in insulin-resistant humans, show elevated lactate production in both in vitro and in vivo studies. 78, 79 Accordingly, increased fasting lactate levels in plasma are observed in insulin-resistant obese humans and associate with whole-body insulin resistance. 80 Elevated plasma lactate levels were shown to induce hepatic gluconeogenesis and impair glucose uptake in muscle 81 ( Figure 4 ).
Abnormal mitochondrial function in adipose tissue of mice leads to inflammation and enhances whole-body insulin resistance. Inflammation and adipocytes hypertrophy can further lead to hypoxia in adipose tissue. Hypoxia in VAT induces hypoxia-inducible factor 1 α (HIF1α) with subsequent inhibition of sirtuin 2 (SIRT2), which lead to diminished deacetylation PGC1α with consecutive lower β-oxidation. 82 Insulin-resistant obese humans revealed higher HIF1α and lower SIRT2 protein levels as well as lower expression of genes involved in FA oxidation, mitochondrial biogenesis, respiratory chain and ATP synthase in mitochondria of human adipose tissue when compared to lean controls 82 (Table 1 , Figure 4 ).
In agreement with results in humans, studies in mice analysing the effects of thiazolidinediones on mitochondrial function suggested that increased mitochondrial oxidative capacity in adipocytes induces whole-body insulin sensitization. 83 Whereas more than the half of analysed genes coding for mitochondrial function were downregulated in adipose tissue of obese mice previous to the treatment with rosiglitazone, after treatment about half of those genes were upregulated. 83, 84 Increased mitochondrial mass and enhanced oxygen consumption were suggested to increase lipid utilization in adipose tissue of mice, which improves whole-body insulin sensitivity. 84 Furthermore, thiazolidinediones were shown to increase transcription of genes for glycerol synthesis with subsequent initiation of FA esterification on glycerol backbone in adipocytes for triacylglycerol synthesis, 65, 83, 85 which improves whole-body insulin sensitivity. Since intact mitochondrial function is required for glycerol synthesis, 85 dysfunctional mitochondria may affect production of glycerol and consecutive triacylglycerol synthesis in adipose tissue.
| CONCLUSIONS
Visceral adipose tissue displays higher lipolytic activity and lower insulin sensitivity than SAT. Thus, VAT contributes to the portal delivery of glycerol and FA to the liver for hepatic triacylglycerol storage and interaction with insulin signalling. On the other hand, SAT has a greater capacity for FA storage in the form of triacylglycerol and thereby helps to protect insulin-sensitive tissues from lipotoxic effects. DSAT exhibits higher lipolysis and lower GLUT4 protein expression compared to SSAT. However, functional data analysing FA metabolism in these depots to explore the relevance for insulin resistance in humans need to be addressed in future studies. This review focused exclusively on the role of white adipose tissue energy metabolism for insulin resistance in humans. Of note, adipose tissue changes can occur simultaneously in BAT, which may be even mainly responsible for insulin resistance at least in mice with a hereditary defect of adipose energy metabolism. 86 While it cannot be excluded that BAT also affects the human metabolic phenotype, significant effects have been reported at present only for certain conditions of experimental BAT induction in humans. 5 This does not preclude that pharmacological modulation of BAT function and hereditary disorders in related pathways might be of relevance in the future.
In insulin-resistant humans, excessive lipolysis and impaired lipogenesis in adipose tissue not only stimulated the release of glycerol and FA, but also modified cytokine secretion. These mediators promote ectopic lipid accumulation and low-grade inflammation resulting in insulin resistance in liver and skeletal muscle (Figure 4 ). In addition, adipose tissue of insulin-resistant humans exhibits lower expression of proteins involved in mitochondrial function, which may alter adipocyte mitochondrial function and systemic insulin sensitivity due to enhanced release of lipid metabolites and lactate. However, the relevance of energy metabolism in adipose tissue for the physiological regulation of whole-body insulin sensitivity in humans remains to be elucidated.
